Logo

Luminex

Luminex Obtains CE Marking for MDx Panel to Detect Flu A/B, RSV, COVID-19

Results are generated in a single workflow from a patient sample, which enables rapid detection for the differential diagnosis of a single pathogen.

DiaSorin Expects 2022 Revenue Growth From Base Business, Luminex as COVID-19 Testing Declines
Premium

DiaSorin CEO Carlo Rosa said that demand for the firm's SARS-CoV-2 tests peaked during the Omicron wave in December and January but declined sharply in recent weeks.

DiaSorin 2021 Revenues Rise 41 Percent on SARS-CoV-2, Luminex Sales Growth

Luminex contributed €195.0 million to DiaSorin's revenues in 2021 and saw strong performance from its Aries and Verigene molecular diagnostic platforms.

Luminex Gets CE Mark for Gastrointestinal Pathogen Panel

The molecular multiplex panel is designed to detect 16 pathogens associated with gastrointestinal infections in stool samples.

Genetic Analysis Receives CE Mark for Microbiome Test on Luminex Magpix Instrument

Receipt of the CE mark will provide the Norwegian firm access to the large number of labs that already have the platform, expanding its addressable market, it said.

Nov 11, 2021

DiaSorin Q3 Revenues Rise 51 Percent on Luminex Acquisition, Recovery of Non-COVID Test Sales

Jul 30, 2021

DiaSorin Q2 Revenues Rise 20 Percent on SARS-CoV-2 Testing Demand

May 14, 2021

DiaSorin Q1 Revenues Rise 53 Percent on SARS-CoV-2 Testing Demand

Apr 13, 2021

With Luminex Acquisition, DiaSorin to Broaden MDx Portfolio, Expand US Presence
Premium

Apr 12, 2021

DiaSorin to Acquire Luminex for $1.8B

Mar 4, 2021

Luminex Obtains FDA Emergency Use Authorization for Expanded Respiratory Panel With SARS-CoV-2

Feb 25, 2021

Luminex Shares Surge on Rumor of Acquisition by DiaSorin

Feb 19, 2021

Luminex Nabs $11.3M From BARDA to Develop Test for SARS-CoV-2, Flu, RSV

Feb 9, 2021

Luminex Moving Ahead With EUA Applications Despite Deprioritization of SARS-CoV-2 Test Submission
Premium

Feb 8, 2021

Luminex Q4 Revenues Rise 23 Percent; FDA Deprioritizes EUA Submission for COVID-19 Test

Jan 14, 2021

JP Morgan Healthcare Conference 2021, Day 3: Exact Sciences, Danaher, NanoString, Bio-Techne, More

Jan 12, 2021

Luminex Preliminary Q4 Revenues Increase 23 Percent on MDx Strength

Nov 5, 2020

Luminex Q3 Revenues Rise 35 Percent on Coronavirus Testing Demand

Oct 7, 2020

Luminex Preliminary Q3 Revenues Rise 35 Percent on Pandemic-Related Demand

Sep 8, 2020

As Flu Season Nears, Dx Companies Shift Attention to Multiplex Tests for SARS-CoV-2, Influenza
Premium

Aug 27, 2020

As Abbott Stock Rises on EUA for Antigen Test, Competitors' Shares Take a Hit

Aug 5, 2020

Luminex Responds to FDA Warning Letter While Ramping SARS-CoV-2 Test Manufacturing
Premium

Aug 4, 2020

Luminex Q2 Revenues Rise 32 Percent on Pandemic-Related Sales

Jul 8, 2020

Luminex Preliminary Q2 Revenues Rise More Than 30 Percent on Pandemic-Related Sales

Jun 30, 2020

FDA Issues Warning Letter to Luminex

Breaking News
The Scan

Billion-Dollar Diversity Initiative

The Howard Hughes Medical Institute is now accepting applications for its new $1.5 billion initiative to boost the diversity of the scientific workforce.

Biotech Co-Founder Arrested

A co-founder of a Los Angeles-based biotech company has been arrested in connection with a murder-for-hire scheme, according to Endpoint News.

Return of the Tasmanian Tiger

The Washington Post reports that a team in Australia is working to bring the thylacine back from extinction.

Nature Papers on Genome of Individual From Pompeii, CircRNA Study Best Practices, More

In Nature this week: first sequenced genome of a person from Pompeii, best practice guidelines for circRNA studies, and more.